Aria CV

Category Archives

Aria completes $31m Series B for its pulmonary hypertension treatment device

Pulmonary arterial hypertension (PAH) treatment developer Aria CV announced today that it completed a $31 million Series B financing round. The proceeds Read more...

Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced that Read more...

Aria CV Wins TCT 2018 Shark Tank Competition

Newswise — SAN DIEGO – September 24, 2018 – The Cardiovascular Research Foundation (CRF) is pleased to announce that Aria CV has won the TCT 2018 Read more...

Aria CV, Inc. Closes on $7.8 million Series A Financing

SAINT PAUL, MN — July 24, 2015 — Aria CV, Inc., a developer of medical devices treating pulmonary hypertension, a serious condition that may lead to Read more...

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184